It is encouraging to see investment deals and M&A transactions picking up as the year progresses with some noticeable headline grabbing the attention. It is also the case that many of the deal flow landscape is dominated by investment from US funds and corporates. A part of the 2024 One Nucleus Boston Bootcamp and Breakfast at BIO learning was around how UK companies could gain the attention of US investors and how did the terms sheets compare to the UK. This Genesis Fringe session will continue that discussion among peers as companies develop their plans and narratives for the forthcoming JP Morgan Week and beyond at the start of 2025.

Agenda:

11.30    – Registration & Networking
12.00 – Welcome from the hosts
12.10 – Presentation – Accessing Investment & Deals
Timothy Erhlich, Partner, Gunderson Dettmer and tbc, Taylor Wessing
12.30    – Open Q&A
13.00 – Networking Lunch
13.45 - Close

Registration:

This event is free to attend, invite only and is particularly aimed at attendees from:

•            Life Science R&D companies

•            TechBio companies

•            Tech Transfer Offices/Academia

•            Investors

To request an invitation, please email Tony Jones directly.